Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
收藏www.statista.com2021-05-06 更新2025-03-26 收录
下载链接:
https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
下载链接
链接失效反馈官方服务:
资源简介:
Between 2014 and 2018, global expenditures for autoimmune agents and diabetes have each increased by about 15 percent. Spending for major therapeutic classes, such as mental health and hypertension, decreased slightly within the measured period. Diabetes Diabetes mellitus is a condition in which a person’s pancreas fails to produce insulin, causing high blood sugar levels, which in turn causes major health complications if left untreated. Worldwide, about 460 million people (aged 20 to 79) had the condition in 2019, and that number is projected to grow to 700 million by 2045. Roughly a third of the world’s diabetics were located in the Western Pacific region in 2019. Mental healthThere are various types of health issues facing people around the world today. Some of the common mental problems include anxiety disorders, depression, and eating disorders. In 2018, almost thirty percent of adults worldwide stated that mental health was the largest issue facing people in their respective countries. By far the biggest health concern worldwide was cancer that year.
自2014年至2018年间,全球用于自身免疫病药物和糖尿病的医疗支出均增长了约15%。在观测期间,主要治疗类别,如心理健康和高血压的支出略有下降。糖尿病(Diabetes mellitus)是一种由于胰腺无法产生胰岛素而导致血糖水平升高,进而引起严重健康并发症的状况。截至2019年,全球约有4.6亿(20至79岁)人患有此病,预计到2045年这一数字将增至7亿。2019年,全球约三分之一的糖尿病患者位于西太平洋地区。心理健康全球范围内,人们面临着各种健康问题。其中常见的心理问题包括焦虑症、抑郁症和饮食障碍。2018年,近三分之一的全球成年人表示,心理健康是他们所在国家面临的最大问题。当年,癌症无疑是全球最大的健康担忧。
提供机构:
Statista



